Home > News

   
  •  FOCUS ON

                - Oct 2009: Chemistry Today - Growing challenges of API process development
                in custom manufacturing - Yves Robin,Catherine Mercier.

                (Download PDF file)

                 - October 2009: Isochem receives a GMP certificate from AFSSAPS for
                 Vitamin E TPGS (Vitamin E, D-alpha-tocopheryl polyethylene glycol 1000
                succinate) manufacture
                Isochem was granted a GMP compliance certificate for Vitamin E TPGS
                production by the Drug French Authorities, AFSSAPS (Agence Française de
                Sécurité Sanitaire des Produits de Santé). The GMP certificate granted after an
                audit in Gennevilliers, France during July 2009 reflects the merit of the company’s
                good manufacturing practices and guarantees value to Isochem’s customers
                who rely on high quality Vitamin E TPGS.
                Vitamin E TPGS is a multi-task excipient used in nutraceutical and pharmaceutical
                fields. It has proved its acknowledged utility to improve the bioavailability of poorly
                absorbed drugs acting as a solubilizer, absorption and permeability enhancer.
                As a water soluble compound, Vitamin E TPGS is also used as an efficient source
                of Vitamin E, for therapeutic purposes and in the food industry.
                Over the last two years Isochem has manufactured large quantities of Vitamin E
                TPGS for customers worldwide thus strengthening its position as a key partner of
                 the pharmaceutical market’s major actors.


                 - ISOCHEM invests at its Vert-le-Petit site
                The ISOCHEM Vert-le-Petit site is a GMP site, specialized in phosgenation,
                amino acid and peptide chemistry. It groups R&D forces and ISOCHEM’s main
                pilot workshop. The c-GMP investment underway at the Vert-Le-Petit pilot plant
                will equip the site with a controlled atmosphere clean room (class 10,000)
                as well as airlocks for product, for equipment and staff, and a washing facility
                for small equipment. ISOCHEM thus equips its pilot workshop with a
                state-of-the-art environment for the routine production of active pharmaceutical
                ingredients (API).ISOCHEM also plans to be audited by the FDA before the end
                of 2010. This represents a nearly 600 K€ investment.

                 - September 2009: Participation in the 20th International Conference on
                 "Organic Process Research & Development" in Lisbon from 9 to 11 September.
                Oral presentation of our NCA production technology entitled "Production process
                of a -Amino acid N-CarboxyAnhydrides: Batch process development, scale-up
                concerns and industrial solution".

                 - June 2009: Yves Robin of Isochem shows how hydrogenation is often a key
                technology in the outsourcing of multi-step fine chemical syntheses
                (Download PDF file)

                 - April 2009: Heads up: The new technical data sheet of Vitamin E TPGS
                now available (Download PDF file)

  •  ARCHIVES

  •  2010 EXHIBITIONS & EVENTS

    Village de la Chimie Parc Floral de Paris (Vincennes) 12-13 February n°-
    INFORMEX San Francisco (USA) 16+17-19 February n°1028
    CPhI EUROPE Paris Nord Villepinte (France) 5-7 October n°-

     

     

     

  • New pilot facility in Vert-le-petit
    New pilot facility in Vert-le-petit
     
    Visit GROUPE SNPE | Site map | Legal notice